These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 91483)

  • 21. Methadone effects on brain functioning and type A and B CNV shapes.
    Tecce JJ; Cole JO; Mayer J; Lewis DC
    Psychopharmacology (Berl); 1979 Sep; 65(1):21-5. PubMed ID: 116287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personality traits influence the effects of diazepam and caffeine on CNV magnitude.
    Münte TF; Heinze HJ; Künkel H; Scholz M
    Neuropsychobiology; 1984; 12(1):60-7. PubMed ID: 6514179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Task related changes in contingent negative variation (CNV) response of endogenous evoked potentials.
    Sahai V; Tandon OP
    Indian J Physiol Pharmacol; 2000 Jul; 44(3):311-6. PubMed ID: 10941619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man.
    Benowitz NL; Jones RT; Lerner CB
    J Clin Endocrinol Metab; 1976 May; 42(5):938-41. PubMed ID: 1270583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. delta 9-Tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat dentate gyrus.
    Campbell KA; Foster TC; Hampson RE; Deadwyler SA
    J Pharmacol Exp Ther; 1986 Dec; 239(3):936-40. PubMed ID: 3025423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention.
    Verrico CD; Jentsch JD; Roth RH; Taylor JR
    Neuropsychopharmacology; 2004 Mar; 29(3):522-9. PubMed ID: 14694348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC).
    Scallet AC; Uemura E; Andrews A; Ali SF; McMillan DE; Paule MG; Brown RM; Slikker W
    Brain Res; 1987 Dec; 436(1):193-8. PubMed ID: 2825925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorpromazine effects on brain activity (contingent negative variation) and reaction time in normal women.
    Tecce JJ; Cole JO; Savignano-Bowman J
    Psychopharmacologia; 1975 Sep; 43(3):293-5. PubMed ID: 1187962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies of effects of chlorpromazine on the contingent negative variation.
    Kuda K; Fujitani Y; Oikawa T
    Folia Psychiatr Neurol Jpn; 1978; 32(4):579-84. PubMed ID: 750345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marijuana's acute effects on cognitive bias for affective and marijuana cues.
    Metrik J; Aston ER; Kahler CW; Rohsenow DJ; McGeary JE; Knopik VS
    Exp Clin Psychopharmacol; 2015 Oct; 23(5):339-50. PubMed ID: 26167716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of electrical correlates of sensory processing by tetrahydrocannabinol.
    Pontzer NJ; Hosko MJ; Wilkison DM
    Exp Neurol; 1986 Jan; 91(1):127-35. PubMed ID: 3000809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barbiturate effects on brain functioning (CNV) and attention performance in normal men [proceedings].
    Tecce JJ; Cole JO; Mayer J; Lewis DC
    Psychopharmacol Bull; 1977 Apr; 13(2):64-6. PubMed ID: 860002
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial.
    Ahmed AI; van den Elsen GA; Colbers A; van der Marck MA; Burger DM; Feuth TB; Rikkert MG; Kramers C
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1475-82. PubMed ID: 25035121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin-releasing hormone enhances event-related brain potentials and growth hormone release in man.
    Strollo F; Amabile G; Fattapposta F; Strollo G; More M; Riondino G
    Neurosci Lett; 1988 Nov; 93(2-3):346-53. PubMed ID: 3149400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential impairments of selective attention due to frequency and duration of cannabis use.
    Solowij N; Michie PT; Fox AM
    Biol Psychiatry; 1995 May; 37(10):731-9. PubMed ID: 7640328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term cannabis use on selective attention: an event-related potential study.
    Solowij N; Michie PT; Fox AM
    Pharmacol Biochem Behav; 1991 Nov; 40(3):683-8. PubMed ID: 1806953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methodological aspects of the analysis of the effects of drugs (diazepam and caffeine) on contingent negative variation].
    Heinze HJ; Münte TF; Künkel H; Dickmann K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1985 Jun; 16(2):69-74. PubMed ID: 3930214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.